Table 4. Baseline characteristics of patients with RVR and non-RVR.

Parameter*	RVR+ n = 573			non-RVR+ n = 226			p-value
	Value	Range	n =	Value	Range	n =
Male [%]	65		n = 365/562	68		n = 151/223	0.4614
Age [years]	42.1±11.1	2.5–81.8	n = 560	48.3±9.7	20.1–66.4	n = 221	<0.0001
Weight [kg]	76.3±16.9	40.0–150.0	n = 557	76,0±16.3	47.0–140.0	n = 224	0.5197
BMI	25.2±4.8	15.2–51.2	n = 551	25.0±4.5	16.7–45.9	n = 221	0.5462
CoO Germany [%] ++	58		n = 311/540	63		n = 142/214	0.1374
Genotype 3 [%]	80		n = 445/554	86%		n = 193/224	0.0550
HCV RNA [log 10 IU/mL]	5.8±1.0	1.9–8.7	n = 563	6.1±0.8	2.7–7.5	n = 221	<0.0001
ALT [U/L]	2.3±2.5	0.3–27.8	n = 543	2.0±2.3	0.2–12.5	n = 219	0.5226
Cirrhosis [%]	6		n = 33/573	11		n = 25/226	0.0093
Steatosis [%]	29		n = 136/470	33		n = 60/184	0.3566
Dose of IFN ** [µg/kg BW # ]	1.5±0.7	0.5–13.8	n = 543	1.5±0.4	1.0–3.3	n = 221	0.4437
Dose of RBV ∼ [mg/kg BW # ]	13.3±2.0	4.2–22.7	n = 539	13.5±2.2	1.8–28.6	n = 216	0.7976

*Continuous values are indicated in median.

⁺Not all parameters are available for each patient. Only available parameter were considered for calculations.

⁺⁺Country of Origin.

**Interferon.

^∼Ribavirin.

^#body weight.